Epigenetics: environmental instructions for the genome.
The field of epigenetics has existed for decades, springing from genetic studies of the phenotypic variability of diverse biologic readouts such as eye color in Drosophila (Muller 1930; Schultz 1950), mating cassette silencing in yeast (Hawthorn 1963), and X chromosome reactivation in mammals (Lyon 1961). These early genetic studies resulted in the establishment of functional relationships among various factors in regulation of gene expression through analysis of their genetic interactions. Biochemical identification and characterization of enzymatic machinery responsible for DNA modification (Bestor et al. 1988; Okano et al. 1998) and histone modification patterns (Brownell et al. 1996; Taunton et al. 1996) in the 1980s and 1990s led to a greater appreciation of the underlying biochemical principles of epigenetic regulation (Fischle et al. 2003; Rea et al. 2000). These studies relied heavily on prior genetic data and provided mechanistic insight into how genetic modifiers of eye color variegation, for example, regulate gene expression (Fischle et al. 2003; Rea et al. 2000).
A unifying concept central to a modern, molecular view of epigenetics postulates that the pattern of modifications (both of DNA and of histone proteins themselves) provides information content that instructs the enzymes integral to nuclear physiology (Jaenisch and Bird 2003; Strahl and Allis 2000). Importantly, although chromosomes are dynamic organdies, the epigenetic information can be quite stable, surviving multiple rounds of mitotic cell division (Cavalli and Paro 1998), meiosis (Cavalli and Paro 1998), or even nuclear transfer (Ng and Gurdon 2005). In a sense, the chromosome contains two intertwined types of information: the linear sequence of nucleotide bases in DNA codes for biologic macromolecules, and the regulatory information embedded in the nucleoprotein architecture of chromatin specifies which regions of the genome are active in any given cell. Epigenetic regulation is a primary driving force behind the creation of different cell types, each with the DNA sequence, during development of multicellular organisms. A seminal finding that monozygotic twins are epigenetically indistinguishable early in life but, with age, exhibit substantial differences in epigenetic markers underscores the important role played by the environment in shaping the epigenome (Fraga et al. 2005).
Given the importance of epigenetic regulation to normal nuclear function, it is pertinent to ask whether alterations in this form of regulation might impact disease. Components of the epigenetic machinery, in fact, are altered in various human diseases including neurologic disorders (e.g., Rett syndrome and [alpha]-thalassemia X-linked mental retardation), congenital malformation (e.g., Rubinstein Taybi syndrome), immune disorders (e.g., ICF syndrome), and even aging. Epigenetic alterations also constitute the molecular basis of pathology associated with loss of imprinting (e.g., Prader-Willi, Angelman, and Beckwith-Weidemann syndromes). Moreover, there are multiple connections between epigenetic errors and neoplasia including alterations in genomic DNA methylation (Ballestar and Esteller 2005) and histone acetylation patterns (Ballestar and Esteller 2005; Slany 2005).
The current excitement over epigenetics and its potential as a tool for diagnosis and treatment of human disease seems warranted. However, there are still important knowledge gaps in the field. The solution of the structure of DNA by Watson and Crick in the 1950s (Watson and Crick 1953) immediately suggested a mechanism--semi-conservative replication--by which the genetic material could be faithfully transmitted from one generation to the next. A major dilemma for the field of epigenetics concerns how the regulatory information embedded in the protein constituents of chromatin is replicated during S phase. Identification of the mechanisms involved in faithfully copying the epigenetic information will represent an important conceptual advance. Additionally, we do not currently understand the "language" of epigenetics. Deciphering the genetic code revealed the language used by DNA to propagate information. The current stare-of-the-art translation of epigenetic cues is both crude and limited in scope. Despite the considerable progress made in this area over the past decade, scientists are only beginning to decipher the information embedded in chromatin. The alphabet of epigenetics is not completely described and, importantly, the mechanism by which cells read and interpret this information is also largely unknown.
Epigenetic information promises to serve as an important adjunct to DNA sequence in the analysis of biologic response to environmental exposures. Obviously, biologic parameters that contribute to the functionality of DNA will be affected by exposure in much the same manner as DNA sequence (by mutation). A major difference between epigenetic and genetic outcomes is that while DNA sequence is static, the epigenome is a dynamic entity that changes with cell type, during the cell cycle, in response to biologic signaling systems, and with environmental changes. Deciphering how the epigenome responds to environmental exposures and how it predicts disease risk holds great promise and will undoubtedly prove an important adjunct to mutational analyses. Recently, multiple reports have linked epigenetic mechanisms to the phenotypic effects of environmental exposures during critical periods of development (Anway et al. 2005). In real human terms, these exposures result from such variable behaviors as nutrition and lifestyle. Some of these may have a direct influence on embryonic development, whereas others may exert their effects later in life, as predicted by the Barker hypothesis (Barker 1990).
Although current understanding of epigenetics lags behind our more fundamental understanding of the information content in DNA sequence, the epigenome will undoubtedly serve as a therapeutic target in the future. In fact, epigenetic therapies are currently under investigation in diverse diseases including cancer, sickle cell anemia, and thalassemias (de Vos 2005). Personalized medicine will certainly be affected by epigenetic differences between individuals and the contributions of this epigenetic polymorphism to disease onset, severity, and outcome. The seemingly limitless potential applications to problems relevant to human health and disease underscore the need to elucidate the basic principles of epigenetic regulation at a molecular level. Understanding the mechanistic basis of how epigenetic regulation is achieved is fundamental to placing this level of biologic regulation in the tool box of environmental health science and medicine.
The authors declare they have no competing financial interests.
Anway MD, Cupp AS, Uzumcu M, Skinner MK. 2005. Epigenetic transgenerational actions of endocrine disrupters and male fertility. Science 308:1486-1469.
Ballestar E, Esteller M. 2005. The epigenetic breakdown of cancer cells: from DNA methylation to historic modifications. Prog Mol Subcell Biol 38:169-181.
Barker DJ. 1990. The fetal and infant origins of adult disease [Editorial]. BMJ 301:1111.
Bester TH, Laudano A, Mattaliano R, Ingram V. 1988. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzyme is related to bacterial restriction methyltransferases. J Mol Biol 203:971-983.
Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, et al. 1996. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation Cell 84:843-851.
Cavalli G, Paro R. 1998. The Drosophila Fab-7 chromosomal element conveys epigenetic inheritance during mitosis and meiosis. Cell 93:505-518
de Vos D. 2005. Epigenetic drugs: a longstanding story. Semin Oncol 32:437-442.
Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S 2003. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromedemains. Genes Dev 17:1878-1881.
Fraga MF, Ballestar E, Paz MF, Repero S, Setien F, Ballestar ML, et al. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102:10604-10609.
Hawthorn DC, 1963. A deletion in yeast and its bearing on the structure of the mating type locus Genetics 48:1727-1729.
Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(suppl):245-254.
Lyon MF 1961. Gene action in the X-chromosome of the mouse. Nature 190:372-373.
Muller HJ. 1930. Types of visible variations induced by X-rays in Drosophila. J Genet 22:299-334.
Ng RK, Burden JR. 2005. Epigenetic memory of active gone transcription is inherited through somatic cell nuclear transfer. Proc Natl Acad Sci USA 102:1957-1962.
Okano M, Xie S, Li E. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19(3):219-220.
Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, et al. 2000, Regulation of chromatin structure by site-specific histone H3 methyltransferases, Nature 406:593-599.
Schultz J. 1950 Interrelations of factors affecting heterochromatin-induced variegation in Drosophila [Abstract]. Genetics 35:134.
Slany RK. 2005. When epigenetics kills: MLL fusion proteins in leukemia Hematol Oncol 23:1-9.
Strahl BD, Allis CD 2000. The language of covalent histone modifications. Nature 403:41-45.
Taunton J, Hassig CA, Schreiber SL 1996. A mammalian histine deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408-411.
Watson JD, Crick FH. 1953. Genetical implications of the structure of deoxyribonucleic acid Nature 171(4361):964-967
Paul A. Wade
Trevor K. Archer
Laboratory of Molecular Carcinogenesis
National Institute of Environmental Health Sciences
National Institutes of Health
Department of Health and Human Services
Research Triangle Park, North Carolina
Trevor K. Archer is chief of the Laboratory of Molecular Carcinogenesis and head of the Chromatin and Gene Expression Section. Paul A. Wade is head of the Eukaryotic Transcriptional Regulation Section. The Laboratory of Molecular Carcinogenesis is dedicated to elucidating the molecular mechanisms, including epigenetics, used by cancer cells to develop and thrive in the hope that understanding mechanisms will lead to improved cancer prevention, diagnosis, and therapy.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Guest Editorial|
|Author:||Archer, Trevor K.|
|Publication:||Environmental Health Perspectives|
|Date:||Mar 1, 2006|
|Previous Article:||A vision that challenges dogma gives rise to a new era in the environmental health sciences.|
|Next Article:||Considering a society of environmental health science.|